Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Acne Therapeutics Market- Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The…
Swiss-based global biopharmaceutical company Debiopharm Group will break up partnership with Allergan, and will transfer commercialisation licence for Trelstar in the US and Canada.
Allergan announced positive 3-month topline results from the second pivotal clinical trial of Bimatoprost SR, a first-in-class sustained-release, biodegradable implant for the reduction of IOP in patients with open-angle glaucoma or ocular hypertension, while the global pharmaceutical leader noted the positive results from the first Phase 3 trial were reported in June 2018.
Allerganhas launched ‘BC Trivia’ featuring actress and new ambassador Shay Mitchell – a fun and engaging trivia quiz designed to…
Allergan is recalling one lot of Taytulla physicians sample pack, indicated for use by women to prevent pregnancy, because of…
Allergan and Medicines360, a global nonprofit women’s health pharmaceutical company dedicated to expanding access to quality medicines, have announced that…
Apricus Biosciences, a biopharmaceutical company urology and rheumatology focused drug-maker, will have to fire another shot at getting its topical cream…
Allergan’s supplemental New Drug Application (sNDA) to expand the approved use of AVYCAZ has gotten the FDA’s approval.
Alergan will have to cut over 1000 jobs from commercial and other functions, the company said on Wednesday.
Allergan has announced that Wayne Swanton has been promoted to Executive Vice President, Global Operations following notification that Rob Stewart,…